Gene · 341
Papers2,927
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,927
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomics profiling of serum and liver in GSD Ia and Ib patients: insights into complication mechanisms and circulation biomarkers. | J Transl Med | 2026 | 41721410 | PubTator, text mining | PubMed |
| Microglia‑mediated neuroinflammation in intracerebral hemorrhage: Pathological mechanisms and implications for therapeutic development (Review). | Int J Mol Med | 2026 | 41716017 | PubTator, text mining | PubMed |
| Longevity vs. Healthy Longevity: Different Outcomes Underlain by Different Mechanisms. | Aging Dis | 2026 | 41701878 | PubTator, text mining | PubMed |
| MBOAT1 Promotes Glioma Progression Through Enhancing Ferroptosis Resistance and Immunosuppressive Microenvironment. | CNS Neurosci Ther | 2026 | 41696943 | PubTator, text mining | PubMed |
| Residual risk in atherosclerotic cardiovascular disease after statin therapy: Clinical mechanisms and management strategies. | World J Cardiol | 2026 | 41694036 | PubTator, text mining | PubMed |
| Lipidome and proteome of astrocyte and microglia ApoE lipoprotein reveal differences based on cell type and ApoE isoform. | J Lipid Res | 2026 | 41692246 | PubTator, text mining | PubMed |
| Tissue-Derived Extracellular Vesicles Define Diagnostic Biomarkers for Renal Cell Carcinoma. | J Extracell Vesicles | 2026 | 41656939 | PubTator, text mining | PubMed |
| Proteomics reveals three molecular subtypes of Alzheimer's disease with distinct progression patterns. | Alzheimers Dement | 2026 | 41650025 | PubTator, text mining | PubMed |
| Integrated regulation of ferroptosis in prostate cancer covering mechanisms, resistance, and translational opportunities. | J Mol Med (Berl) | 2026 | 41639281 | PubTator, text mining | PubMed |
| A common 19 bp APOE enhancer deletion is protective against Alzheimer's disease in African Americans. | Nat Commun | 2026 | 41629326 | PubTator, text mining | PubMed |
| LAR1 promotes breast carcinogenesis by activating NF-κB signaling pathway through binding and enhancing APOC1 expression. | iScience | 2026 | 41623496 | PubTator, text mining | PubMed |
| Application of artificial intelligence in head and neck squamous cell carcinoma. | Ann Med | 2026 | 41593888 | PubTator, text mining | PubMed |
| Single-cell sequencing and network pharmacology coupled with molecular docking and experimental validation reveal the effects of YPFS on macrophages in stage I non-small cell lung cancer. | Cancer Immunol Immunother | 2026 | 41591571 | PubTator, text mining | PubMed |
| Identifying Susceptibility Genes and Shared Genetic Architecture for Longevity and Muscle Weakness. | J Cachexia Sarcopenia Muscle | 2026 | 41588686 | PubTator, text mining | PubMed |
| Ferroptosis-related gene signature predicts prognosis and immunotherapy response in hepatocellular carcinoma: A multi-cohort retrospective study. | Medicine (Baltimore) | 2026 | 41578512 | PubTator, text mining | PubMed |
| Exploring phenotype-related single-cells through attention-enhanced representation learning. | Genome Med | 2026 | 41566378 | PubTator, text mining | PubMed |
| Integrated multi-omics profiling of plasma extracellular vesicles reveals the hsa-miR-1-3p-LRP1 axis as a potential biomarker in cervical cancer. | Mol Clin Oncol | 2026 | 41561825 | PubTator, text mining | PubMed |
| An Immune-privileged niche mediates immunotherapy resistance in esophageal carcinoma. | J Immunother Cancer | 2026 | 41539687 | PubTator, text mining | PubMed |
| Exploring the molecular intersections of osteoporosis and sarcopenia: An integrated bioinformatics and experimental validation. | Exp Gerontol | 2026 | 41534648 | PubTator, text mining | PubMed |
| Airway immune profiles and therapeutic implications of IGF1 in eosinophilic granulomatosis with polyangiitis. | Nat Commun | 2026 | 41501017 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/341/papers?page=4